Let the bashers keep bashing guys.. This was one of LMRA better conference calls. Although much work needs to be done I feel they are on the right path and are actually closer to getting some real orders than some think. Some of the positives are. 1) 6.0M in govie contracts forthcoming (2x last yr rev) 2) LMT relationship to deepen in 2008 (im expecting more orders as the year progresses) 3) 4 system integrater evaluating our 40gbps (2 of them only looking into lmra solution) 4) Telecordia only 3-4 months away.. (this will be the major news that will propell this stoc...
Lumera Corporation Announces Agreement to Develop Millimeter Wave Communication Systems with Asyrmatos, Inc. If you have not downloaded Mojo’s chat room yet you can do so by clicking here! Or you can copy and paste the below link into your browser. http://www.hotconference.com/software/conference.php?id=73991... You do not have to use your real name just pick a screen name that you like and you are in the room.
Time to get to know more about Lumera Corporation’s Bioscience , Electro-Optics , and Plexera of course before the next big move would be better with the current pivot point @ $4.29 and Resistance at $4.57!
Time to get to know more about Lumera Corporation’s Bioscience , Electro-Optics , and Plexera of course before the next big move would be better with the current pivot point @ $4.29 and the resistance at $4.57!
Buy this under $4.00 is a great buy. The corporate overview video will help get you started here . With Podcasts here . Lumera has a new Mojo Crossover and one of the few stocks that can go up 200% overnight.
Time to get to know more about Lumera Corporation’s Bioscience , Electro-Optics , and Plexera of course before the next big move would be better with the current pivot point @ $4.29 and the resistance at $4.57!
Buy this under $4.00 is a great buy. The corporate overview video will help get you started here . With Podcasts here . Lumera has a new Mojo Crossover and one of the few stocks that can go up 200% overnight.
Lumera Corporation Announces Two Bioscience Industry Veterans to Join Plexera Board
BOTHELL, Wash., Sep 05, 2007 (BUSINESS WIRE) -- Lumera Corporation (LMRA), a leader in the emerging field of nanotechnology, announced today that Ulf Jonsson, Ph.D., former CEO of Biacore (now GE Healthcare), and Jim Richey, CEO of Auguron Biosciences, Inc., have joined the Board of Directors of its wholly owned subsidiary, Plexera Bioscience LLC.
Mojo Crossover..... “Trade with Mojo” Blog. Now you can stop looking for reliable indicators just let Mojo and his “Mojo Crossover” with pi...
If you would like to talk to Mojo during the trading day for advice…one of the better ways would be here on the big screen! Now you can stop looking for reliable indicators just let Mojo and his “Mojo Crossover” with pivot points do the work for you.
Time to get to know more about Lumera Corporation’s two core units Bioscience and Electro-Optics of course before the next big move would be better with the current pivot point @ $4.41! Buy this under $4.50 is a great buy. The corporate overview video will help get you started here . Lumera Podcasts here .
Everyday you can find updated buy and sell alerts on many hot stocks here on Predict Wall Street. This is a simple way to make money in the stock market and by using " Mojo Crossover " you will be trading with the flow bullish or bearish. The day-to-day predictions are for day traders or entry points for long-term traders. This is the same method I used to overcome 13,344 registered members to become #1 on PredictWallStreet.com with >70% accuracy on >10,...
Data powered by QuoteMedia.
All Rights Reserved.
Data delayed 15 to 20 minutes unless otherwise indicated.
Terms of Use.
None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.